
Marco Moschini
@uromoschini
MD PhD FEBU, Urologist, Milano, Italy. @EAUYAUrology Urothelial Carcinoma Group
ID: 1581591427
09-07-2013 22:17:21
767 Tweet
1,1K Followers
1,1K Following

Great experience to present about bladder sparing strategies in MIBC patients at the national Polish association meeting. Congrats Pawel Rajwa and wojciech_piotr_krajewski for the great work !



fantastic dinner last night, exchanging ideas and insights with the brilliant minds and speakers Laura S. Mertens Marco Moschini Evanguelos Xylinas Jeremy Teoh anand iyer Jon Aning #UROonco24 EAU Edu Platform UROONCO


What a wonderful #UROonco24 at Budapest! 🙌🏻 Thoroughly enjoyed the high-quality scientific content🥇as well as the friendship & fun after the meeting 🤟🏻Thank you Morgan Roupret #ESOU European Association of Urology (EAU) for all the organisation!! 🙏🏻 #UroSoMe


A #bladdercancer expert panel drafted recommendations on the use of NGS in the management of UCa Oncology Advance 💡Gain insight in molecular diagnostics? ✅Check our #CME cases on this subject: bit.ly/3yv1PPE OncoAlert Marco Moschini ylt Full publication:


Fantastic work Chiara Mercinelli Marco Moschini Alberto Briganti Andrea Necchi & team!!


Amazing consensus meeting for relevant designs/endpoints for bladder preservation trials in MIBC! Andrea Necchi Ashish M. Kamat, MD, MBBS Philippe spiess Matt Galsky Shilpa Gupta Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Emanuele Crupi Sarah P. Psutka MD MS Dr. Jason Efstathiou Marco Moschini Giorgio Brembilla Antonio Cigliola Chiara Mercinelli


Innovazione e ricerca in approccio multidisciplinare: è il primo congresso degli #Uronauti, i giovani urologi accademici riuniti oggi a Roma. Comitato Scientifico: Andrea Mari, Simone Albisinni Simone Albisinni, Daniele Amparore, Riccardo Giuseppe Bertolo 𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD, Riccardo


This month, leading experts will represent the EAU at the following: 🟢12-15 Feb. Sociedad Colombiana de Urología Residents Meeting - Bogota, CO Presenter: Prof. Jean-Nicolas Cornu 🟢 22-23 February Urological Society of India 🇮🇳 - EU Uro Oncology Masterclass - Kolkata, IN Presenters: Prof. Juan Gómez Rivas & Dr. Marco Moschini

Join us March 21st for the 8th edition of Rapid Fire Debates in #BladderCancer #EAU2025 #EAU25 European Association of Urology (EAU) Joan Palou Redorta Gianluca Giannarini Laura S. Mertens Paolo Gontero Carme Mir Benjamin Pradere Marco Moschini fredrik liedberg Marek Babjuk Shilpa Gupta Félix Guerrero-Ramos jim catto Andrea Necchi


In actasurologicas we are happy to share our SPECIAL ISSUE on UROTHELIAL CARCINOMA with our guest editors Andrea Gallioli and Marco Moschini See the following link ⬇️ sciencedirect.com/special-issue/…


🔝 Special Issue – Urothelial Carcinoma Real-life perception of pathology reports in urology (A. Cimadamore, et al.) sciencedirect.com/science/articl… Andrea Gallioli Marco Moschini Óscar Rodríguez Faba AEU Confederación Americana de Urología (CAU) EAU Young Academics


TURBT is underrated and underappreciated by everyone except our patients. Michael E. Rezaee, MD, MPH called 150 of our patients before and 1,2,8,24 hrs,1 week after TURBT. Paper forthcoming. Results show us TURBT is a surgery like any other, with room for improvement and refinement

Join us tomorrow for the signature Rapid Fire Debate Session in Bladder Cancer Now in its 8th edition #EAU2025 #EAU25 Maarten Albersen Paolo Gontero European Association of Urology (EAU) Joan Palou Redorta Gianluca Giannarini Laura S. Mertens Carme Mir Benjamin Pradere Marco Moschini fredrik liedberg Marek Babjuk Shilpa Gupta


That is a very touching moment to say goodbye to 2 friends and impressive urologists in your field. You both will be present and future of European Association of Urology (EAU) EAU Young Urologists


Complete vs partial TURBT for muscle-invasive #BladderCancer treatment. fredrik liedberg, Marco Moschini & Benjamin Pradere join Ashish M. Kamat, MD, MBBS in a discussion on the extent of transurethral resection of bladder tumor needed in #MIBC. They debate the value of complete resection when

Risk stratification for active surveillance in low and intermediate-risk #BladderCancer. Marco Moschini Ospedale San Raffaele and Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center discuss expanding active surveillance criteria for recurrent low-grade bladder cancer. #WatchNow > bit.ly/42wshVz